Analyst Research Report Snapshot

Title:

CONSORT MEDICAL - LIFE AFTER KING

Price:

$10.00

Provider:

Edison Investment Research

Date:

31 Jan 2013

Pages:

5

Type:

AcrobatPDF

Companies referenced:

CSRT.L

Available for Immediate Download
Summary:

Consort Medical will soon consist only of the Bespak division, as the King Systems divestment is set to complete on 15 February. The disposal will bring in an immediate $120m, with a further $10m expected in April and the remaining $40m contingent on a King Vision-based, three-year earn-out. Although the funds will initially be used to strengthen the balance sheet, acquisitions to bolster the Bespak operations are expected. We have also taken the opportunity to review our FY14 forecasts, with revenues decreasing from £102.8m to £99.6m and EPS down from 46.2p to 41.7p.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.